- Home
- BMN vs PRE Comparison
BMN vs PRE Comparison
Compare BMN & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMN | PRE |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | Hong Kong |
| Employees | 19800 | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.8M | 131.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BMN | PRE |
|---|---|---|
| Price | $24.99 | $14.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 29.9K | ★ 135.6K |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 4.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $77,079,000.00 |
| Revenue This Year | N/A | $202.46 |
| Revenue Next Year | N/A | $103.60 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 201.54 |
| 52 Week Low | $21.51 | $3.10 |
| 52 Week High | $25.59 | $17.99 |
Technical Indicators
Market Signals| Indicator | BMN | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 56.26 |
| Support Level | $24.62 | $11.37 |
| Resistance Level | $24.84 | $15.32 |
| Average True Range (ATR) | 0.23 | 1.12 |
| MACD | 0.03 | 0.24 |
| Stochastic Oscillator | 100.00 | 83.57 |
Price Performance
Historical ComparisonAbout BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.